AI assistant
Centessa Pharmaceuticals plc — Director's Dealing 2023
Jun 27, 2023
31309_dirs_2023-06-26_e182dc65-c0fa-4829-b5b8-89df6124fc11.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Centessa Pharmaceuticals plc (CNTA)
CIK: 0001847903
Period of Report: 2023-06-22
Reporting Person: GAP (Bermuda) L.P. (Director, 10% Owner)
Reporting Person: GENERAL ATLANTIC GENPAR (BERMUDA), L.P. (Director, 10% Owner)
Reporting Person: General Atlantic (Lux) S.a r.l. (Director, 10% Owner)
Reporting Person: General Atlantic GenPar (Lux) SCSp (Director, 10% Owner)
Reporting Person: General Atlantic Cooperatief, L.P. (Director, 10% Owner)
Reporting Person: General Atlantic Partners (Lux), SCSp (Director, 10% Owner)
Reporting Person: General Atlantic Partners (Bermuda) EU, L.P. (Director, 10% Owner)
Reporting Person: General Atlantic Partners (Bermuda) IV, L.P. (Director, 10% Owner)
Reporting Person: General Atlantic Cooperatief U.A. (Director, 10% Owner)
Reporting Person: General Atlantic UM B.V. (Director, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-06-22 | Share Option (right to buy) | $6.35 | A | 48000 | Acquired | 2023-06-22 | Ordinary Shares (48000) | Indirect |
Footnotes
F1: The Ordinary Shares subject to the Share Option will vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of shareholders, subject to Dr. Brett Zbar's continued service as a director of the Issuer through the applicable vesting date.
F2: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F3: The Share Option was granted to Dr. Zbar who is an employee of General Atlantic Service Company, L.P., a Delaware limited partnership ("GASC ") and director of the Issuer.
F4: The Share Option granted to Dr. Zbar is held by him solely for the benefit of GASC, which is controlled by the management committee of GASC MGP, LLC (the "Management Committee"). There are eleven members of the Management Committee. Each of the members of the Management Committee disclaims ownership of the shares except to the extent that he has a pecuniary interest therein.